Labelling of haptenic drug with digoxigenin for competitive immunoassay: its application to lesopitron, a new anxiolytic agent
- 31 October 1996
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 15 (1) , 13-19
- https://doi.org/10.1016/0731-7085(96)01789-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activationJournal of Immunological Methods, 1995
- A chiral liquid chromatographic method for the determination of the enantiomers of the racemic triazole antifungal drug (SCH 39304) in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 1995
- Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissuesPeptides, 1994
- Effect of acute administration of the 5‐HT1A receptor ligand, lesopitron, on rat cortical 5‐HT and dopamine turnoverBritish Journal of Pharmacology, 1994
- Luminescent Labels—More than Just an Alternative to Radioisotopes?Angewandte Chemie International Edition in English, 1994
- Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the ratEuropean Journal of Pharmacology, 1994
- The digoxigenin:anti-digoxigenin (DIG) technology—a survey on the concept and realization of a novel bioanalytical indicator systemMolecular and Cellular Probes, 1991
- Analytical methodology for immunoassays and DNA hybridization assays — current status and selected systems — critical reviewClinica Chimica Acta; International Journal of Clinical Chemistry, 1990
- The avidin-biotin complex in bioanalytical applicationsAnalytical Biochemistry, 1988
- [12] Determination of total proteinPublished by Elsevier ,1983